Respiratory syncytial virus (RSV) attachment and entry
Battles MB, McLellan JS. Respiratory syncytial virus entry and how to block it. Nature Reviews Microbiology. 2019 Feb 05;17(4):233–45. doi: 10.1038/s41579-019-0149-x.; Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity. 2017 Feb 21;46(2):301–14. PMID: 28228284; PMCID: PMC7128247.; Lindemans CA, Coffer PJ, Schellens IM, de Graaff PM, Kimpen JL, Koenderman L. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J Immunol. 2006 May 01;176(9):5529–37. doi: 10.4049/jimmunol.176.9.5529. PMID: 16622022.; Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology. J Virol. 2002 Jun;76(11):5654–66. doi: 10.1128/jvi.76.11.5654-5666.2002.